Loading organizations...
§ Private Profile · Cleveland, OH, USA
Specialty clinical laboratory offering advanced biomarker tests for cardiovascular disease prevention, diagnosis, and management.
Cleveland HeartLab is a specialty clinical laboratory based in Cleveland, Ohio, that provides advanced biomarker testing for cardiovascular disease prevention, diagnosis, and management. The company operates a CAP-accredited and CLIA-certified facility that processes proprietary inflammation tests, including novel biomarkers like myeloperoxidase, to assess patient heart disease risk beyond traditional lipid panels. Operating with approximately 91 employees, the laboratory generates an estimated $12.1 million in annual revenue by serving medical clinicians and practitioners across North America, Europe, and Asia. The organization has formed strategic research partnerships with major entities such as Cleveland Clinic and Procter & Gamble to develop new diagnostic tools, and it was ultimately acquired by Quest Diagnostics in 2017. Cleveland HeartLab was originally founded in 2009 as a commercial spin-off from the Cleveland Clinic under the leadership of former chief executive officer Jake Orville.
Cleveland HeartLab has raised $21.4M across 2 funding rounds.
Cleveland HeartLab has raised $21.4M in total across 2 funding rounds.
Cleveland HeartLab has raised $21.4M across 2 funding rounds. Most recently, it raised $18.4M Series B in August 2011.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 22, 2011 | $18.4M Series B | Excel Venture Management, HealthCare Ventures | — | Announced |
| Mar 2, 2010 | $3M Venture Round | — | Glengary, Second Generation, Zapis Capital Group | Announced |
Cleveland HeartLab has raised $21.4M in total across 2 funding rounds.
Cleveland HeartLab's investors include Excel Venture Management, HealthCare Ventures, Glengary, Second Generation, Zapis Capital Group.